Welcome to LookChem.com Sign In|Join Free

CAS

  • or

81480-40-2

Post Buying Request

81480-40-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

81480-40-2 Usage

Uses

Oleic Acid N-Hydroxysuccinimide is an inhibitor of CD36/FAT translocase, and an inhibitor of the mitochondrial respiratory chain. Also it us used in the preparation of ceramide analogues as skin permeation enhancers.

Check Digit Verification of cas no

The CAS Registry Mumber 81480-40-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,4,8 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 81480-40:
(7*8)+(6*1)+(5*4)+(4*8)+(3*0)+(2*4)+(1*0)=122
122 % 10 = 2
So 81480-40-2 is a valid CAS Registry Number.

81480-40-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(9Z)-9-Octadecenoyloxy]-2,5-pyrrolidinedione

1.2 Other means of identification

Product number -
Other names N-oleoyloxysuccinimide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81480-40-2 SDS

81480-40-2Relevant articles and documents

Design and evaluation of clickable gelatin-oleic nanoparticles using fattigation-platform for cancer therapy

Meghani, Nilesh M.,Amin, Hardik H.,Park, Chulhun,Park, Jun-Bom,Cui, Jing-Hao,Cao, Qing-Ri,Lee, Beom-Jin

, p. 101 - 112 (2018)

The principles of bioorthogonal click chemistry and metabolic glycoengineering were applied to produce targeted anti-cancer drug delivery via fattigation-platform-based gelatin-oleic nanoparticles. A sialic acid precursor (Ac4ManNAz) was introduced to the cell surface. Gelatin and oleic acid were conjugated by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide (EDC/NHS) chemistry with the subsequent covalent attachment of dibenzocyclooctyne (DBCO) in a click reaction on the cell surface. The physicochemical properties, drug release, in vitro cytotoxicity, and cellular uptake of DBCO-conjugated gelatin oleic nanoparticles (GON-DBCO; particle size, ~240 nm; zeta potential, 6 mV) were evaluated. Doxorubicin (DOX) was used as a model drug and compared with the reference product, Caelyx. A549 and MCF-7 cell lines were used for the in vitro studies. GON-DBCO showed high DOX loading and encapsulation efficiencies. In A549 cells, the IC50 value for GON-DBCO-DOX (1.29 μg/ml) was six times lower than that of Caelyx (10.54 μg/ml); in MCF-7 cells, the IC50 values were 1.78 μg/ml and 2.84 μg/ml, respectively. Confocal microscopy confirmed the click reaction between GON-DBCO and Ac4ManNAz on the cell surface. Flow cytometry data revealed that the intracellular uptake of GON-DBCO-DOX was approximately two times greater than that of GON-DOX and Caelyx. Thus, the newly designed GON-DBCO-DOX provided a safe and efficient drug delivery system to actively target the anticancer agents.

Mucoadjuvant properties of lipo- and glycoconjugated derivatives of oligochitosans

Svirshchevskaya,Alekseeva,Reshetov,Phomicheva,Parphenyuk,Ilyina,Zueva,Lopatin,Levov,Varlamov

, p. 2030 - 2037 (2009)

Chitosan, (1-4)-2-amino-2-deoxy-beta-d-glucan, is a deacetylated form of chitin, an abundant biodegradable, positively charged natural polysaccharide. Chitosan is used for antigen delivery through mucosal barrier due to its ability to disrupt tight junctions. Here we produced new water-soluble low-molecular weight chitosan (LMW-Chi) lipid derivatives and compared their ability to stimulate humoral response with the effect of unmodified LMW-Chi or its oligosaccharide derivatives. LMW-Chi effectively penetrated into macrophage-like, lymphoid and epithelial cells. It also stimulated in mice IgG production to model proteins delivered either by subcutaneous or intranasal routes. Adjuvant effect of chitosan derivatives was comparable to or lower than that of unmodified LMW-Chi. Thus, it is possible that adjuvant effect is induced by unmodified glucosamine units of chitosan.

Α - galactose ceramide new isomer and its synthetic method

-

Paragraph 0063; 0064, (2017/10/31)

The invention provides an alpha-galactosyl ceramide new isomer and its synthetic method. Configuration of sphingosine chain is changed to 4,5-cis double bond sphingosine chain. According to the invention, reaction steps are shortened, yield is raised, and aftertreatment and purification steps are omitted. The synthetic method can be used for total synthesis of similar glycosyl ceramide and satisfies wide range of development, research and application of different glycosyl ceramide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 81480-40-2